Bromodomain
Read More about this categoryShow Less
Bromodomains are a family of evolutionarily conserved protein modules of approximately 110 amino acids that have been found in chromatin-associated proteins as well as nuclear histone acetyltransferases (HATs). Besides its role in chromatin remodeling, recent studies have identified that bromodomains, as acetyl-lysine binding domains, are able to recognize and bind ε–N-acetylated lysine residues in histone and non-histone proteins. The nuclear magnetic resonance (NMR) spectroscopic analysis reveals that the chemical structure of bromodomains, consisting of four left-handed α-helices (including αZ, αA, αB and αC) connected by two loops (ZA and BC loops), forms a deep hydrophobic cavity serving as the acetyl-lysine recognition site.
Products Related to Bromodomain(44)
- GC43320CPI-268456CAS: 1380087-86-4Purity: >98.00%
CPI-268456 (compound 141) is a potent BRD4 inhibitor with an IC50 of <0.5 μM.
- GC43889I-CBP112 (hydrochloride)CAS: 2147701-33-3Purity: >90.00%
cAMP-responsive element-binding protein binding protein (CREBBP) and E1A-associated protein p300 (EP300) are transcriptional co-activators that modulate DNA replication, DNA repair, cell growth, transformation, and development.
- GC45640TP-238 (hydrochloride)CAS: 2415263-05-5Purity: >99.00%
A neuropeptide with diverse biological activities
- GC50070I-BET 151 dihydrochlorideCAS: 1883545-47-8Purity: >98%
BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes
- GC15747I-BET151 (GSK1210151A)CAS: 1300031-49-5Purity: >99.50%
I-BET151 (GSK1210151A) (GSK1210151A) is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16817 | BI-9564 | 1883429-22-8 | >99.50% | |
BRD9/7 specific inhibitor | ||||
| GC17482 | OF-1 | 919973-83-4 | >98.00% | |
BRPF1B and BRPF2 bromodomain inhibitor | ||||
| GC17973 | OTX-015 | 202590-98-5 | >99.50% | |
OTX-015 inhibits the binding of BRD2, BRD3, and BRD4 to acetylated histone 4 in a concentration-dependent manner, with IC 50 values from 92-112nM. | ||||
| GC18750 | NEO2734 | 2081072-29-7 | >99.50% | |
An orally active dual p300/CBP and BET bromodomain selective inhibitor | ||||
| GC43320 | CPI-268456 | 1380087-86-4 | >98.00% | |
CPI-268456 (compound 141) is a potent BRD4 inhibitor with an IC50 of <0.5 μM. | ||||
| GC43889 | I-CBP112 (hydrochloride) | 2147701-33-3 | >90.00% | |
cAMP-responsive element-binding protein binding protein (CREBBP) and E1A-associated protein p300 (EP300) are transcriptional co-activators that modulate DNA replication, DNA repair, cell growth, transformation, and development. | ||||
| GC45503 | L-Moses (hydrochloride) | - | >98.00% | |
| ||||
| GC45640 | TP-238 (hydrochloride) | 2415263-05-5 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46675 | 4-Phenyl-2-pyrrolidinone | 1198-97-6 | >98.00% | |
A precursor and synthetic intermediate | ||||
| GC48408 | TW9 | 2614417-90-0 | >98.00% | |
A dual inhibitor of BRD4 and HDAC1 | ||||
| GC49029 | CAY17c | 2414373-11-6 | >98.00% | |
An inhibitor of BRD4 and class I and class IIb HDACs | ||||
| GC50070 | I-BET 151 dihydrochloride | 1883545-47-8 | >98% | |
BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes | ||||
| GC60182 | GSK046 | 2474876-09-8 | >98.00% | |
GSK046 (iBET-BD2) is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins, with IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively. | ||||
| GC14199 | RVX-208 | 1044870-39-4 | >99.00% | |
RVX-208 (RVX-208) is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. The IC50s are 87 μM and 0.51 μM for BD1 and BD2, respectively. | ||||
| GC15747 | I-BET151 (GSK1210151A) | 1300031-49-5 | >99.50% | |
I-BET151 (GSK1210151A) (GSK1210151A) is a BET bromodomain inhibitor which inhibits BRD4, BRD2, and BRD3 with pIC50 of 6.1, 6.3, and 6.6, respectively. | ||||
| GC17073 | I-BET-762 | 1260907-17-2 | >99.00% | |
I-BET-762 (I-BET762; GSK525762) is a BET bromodomain inhibitor with IC50 of 32.5-42.5 nM. | ||||
| GC18096 | UNC669 | 1314241-44-5 | >98.50% | |
L3MBTL antagonist,potent and selective | ||||
| GC13148 | MS436 | 1395084-25-9 | >99.00% | |
BRD4 inhibitor | ||||
| GC14063 | GSK1324726A | 1300031-52-0 | >98.00% | |
BET proteins inhibitor | ||||
| GC14699 | CPI-203 | 1446144-04-2 | >99.00% | |
BET bromodomain inhibitor | ||||
